Megathread: Can Eli Lilly’s Miracle Drug Propel Its Stock to New Heights

Eli Lilly has recently gained attention for its breakthrough drug, sparking discussions about its potential impact on the pharmaceutical industry and the company’s stock performance.

What does this mean for investors, the healthcare sector, and patients worldwide?

Will this “miracle drug” revolutionize its market segment?
Could it lead to sustained growth in Eli Lilly’s stock?
Are there any risks or challenges investors should consider?
Let’s dive into the details and share insights on this exciting development

If this drug lives up to the hype, it could dominate its market for years—Eli Lilly might become untouchable in that segment. But let’s not forget how often ‘miracle drugs’ face delays or setbacks in real-world usage.

Idk if its safe to bet on the stock. Eli Lilly prices the drugs like shit and knockoffs take off real fast. Its great if it works, but I’d be a little skeptical about it.

Check out this article : https://www.fiercepharma.com/pharma/lilly-expands-its-clampdown-against-sellers-copycat-versions-mounjaro